Literature DB >> 20185892

Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases.

F Dhaille1, V Viseux, A Caudron, A Dadban, C Tribout, P Boumier, A Clabaut, C Lok.   

Abstract

We report two cases of cutaneous granuloma induced by anti-TNF-alpha therapy: a 47-year-old man suffering from psoriatic arthritis treated with infliximab and a 56-year-old woman treated with adalimumab for polyarticular juvenile rheumatoid arthritis. The biospies confirmed the diagnosis of a 'sarcoidosis-like' reaction. No systemic involvement was observed. Such cases of noninfectious granulomatous diseases occurring during anti-TNF-alpha therapy are becoming increasingly frequent. 2010 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20185892     DOI： 10.1159/000275676

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


  20 in total

1.  Treatment of widespread granuloma annulare with adalimumab: a case report.

Authors:  Heidi Kozic; Guy F Webster
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

Review 2.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

3.  Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.

Authors:  Peter Korsten; Nadera J Sweiss; Ulf Nagorsnik; Timothy B Niewold; Hermann-Josef Gröne; Oliver Gross; Gerhard A Müller
Journal:  Am J Kidney Dis       Date:  2010-10-25       Impact factor: 8.860

Review 4.  Cytokine modulators in the treatment of sarcoidosis.

Authors:  E Bargagli; C Olivieri; P Rottoli
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 5.  Isolated intramedullary neurosarcoidosis of the thoracic spine: case report and review of the literature.

Authors:  Bradley S Duhon; Lubdha Shah; Meic H Schmidt
Journal:  Eur Spine J       Date:  2011-05-20       Impact factor: 3.134

6.  [Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].

Authors:  L Leister; A Körber; J Dissemond
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

Review 7.  Adaptive immune responses in primary cutaneous sarcoidosis.

Authors:  Matteo Bordignon; Paola Rottoli; Carlo Agostini; Mauro Alaibac
Journal:  Clin Dev Immunol       Date:  2011-03-30

8.  An in silico modeling approach to understanding the dynamics of sarcoidosis.

Authors:  Baltazar D Aguda; Clay B Marsh; Michael Thacker; Elliott D Crouser
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

9.  Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry.

Authors:  Nadera J Sweiss; Wei Zhang; Beverly S Franek; Silvia N Kariuki; David R Moller; Karen C Patterson; Peggy Bennett; Lakshmi R Girijala; Vaisak Nair; Robert P Baughman; Joe G N Garcia; Timothy B Niewold
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  A case series of refractory cutaneous sarcoidosis successfully treated with infliximab.

Authors:  Papapit Tuchinda; Matthew Bremmer; Anthony A Gaspari
Journal:  Dermatol Ther (Heidelb)       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.